| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.38 | 0.04 |